Service de Néphrologie et Rhumatologie Pédiatrique, Centre de référence des maladies rénales rares, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Bron, France.
Transpl Int. 2013 Feb;26(2):154-61. doi: 10.1111/tri.12014. Epub 2012 Dec 10.
Data on long-term outcomes after pediatric renal transplantation (Tx) are still limited. We report on a 20-year single-center experience. Medical charts of all consecutive pediatric Tx performed between 1987 and 2007 were reviewed. Data of patients who had been transferred to adult units were extracted from the French databases of renal replacement therapies. Outcomes were assessed using Kaplan-Meier and Cox models. Two hundred forty Tx were performed in 219 children (24.1% pre-emptive and 17.5% living related donor Tx). Median age at Tx was 11.1 years and median follow-up was 10.4 years. Patient survival was 94%, 92%, and 91% at 5, 10, and 15 years post-Tx, respectively. Overall, transplant survival was 92%, 82%, 72%, and 59% at 1, 5, 10, and 15 years post-Tx, respectively. The expected death-censored graft half-life was 20 years. Sixteen patients developed malignancies during follow-up. Median height at 18 years of age was 166 cm in boys and 152 cm in girls with 68% of patients being in the normal range. The proportion of socially disadvantaged young people was higher than in general population. Excellent long-term outcomes can be achieved in pediatric renal Tx, but specific problems such as malignancies, growth, and social outcome remain challenging.
关于儿科肾移植(Tx)后长期结果的数据仍然有限。我们报告了一个 20 年的单中心经验。回顾了 1987 年至 2007 年间进行的所有连续儿科 Tx 的病历。从法国肾脏替代治疗数据库中提取了已转至成人单位的患者的数据。使用 Kaplan-Meier 和 Cox 模型评估结果。在 219 名儿童中进行了 240 次 Tx(24.1%为抢先性 Tx,17.5%为活体亲属供者 Tx)。Tx 时的中位年龄为 11.1 岁,中位随访时间为 10.4 年。患者生存率分别为 Tx 后 5、10 和 15 年的 94%、92%和 91%。总体而言,Tx 后 1、5、10 和 15 年的移植生存率分别为 92%、82%、72%和 59%。预计死亡相关移植物半衰期为 20 年。16 名患者在随访期间发生恶性肿瘤。男孩 18 岁时的身高中位数为 166cm,女孩为 152cm,68%的患者处于正常范围内。社会弱势群体年轻人的比例高于一般人群。儿科肾 Tx 可以取得优异的长期结果,但仍存在一些特定问题,如恶性肿瘤、生长和社会结果。